JAMA Pediatrics最新文献

筛选
英文 中文
Confronting Gaps in the Evidence for Youth Suicide Prevention-Why Inaction Is Not an Option. 面对青少年自杀预防证据的空白——为什么不作为不是一种选择。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-29 DOI: 10.1001/jamapediatrics.2025.3482
Laura M Prichett,Emily E Haroz,Holly C Wilcox
{"title":"Confronting Gaps in the Evidence for Youth Suicide Prevention-Why Inaction Is Not an Option.","authors":"Laura M Prichett,Emily E Haroz,Holly C Wilcox","doi":"10.1001/jamapediatrics.2025.3482","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3482","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"326 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182691","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What RSV Is and Why Immunization Matters. 什么是呼吸道合胞病毒,为什么免疫很重要。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-29 DOI: 10.1001/jamapediatrics.2025.3096
Alistair Mukondiwa,Callie L Brown,Lindsay A Thompson
{"title":"What RSV Is and Why Immunization Matters.","authors":"Alistair Mukondiwa,Callie L Brown,Lindsay A Thompson","doi":"10.1001/jamapediatrics.2025.3096","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3096","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"66 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182684","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Why We Should Be Concerned About an Autism Registry. 为什么我们应该关注自闭症登记。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-29 DOI: 10.1001/jamapediatrics.2025.3459
David S Mandell
{"title":"Why We Should Be Concerned About an Autism Registry.","authors":"David S Mandell","doi":"10.1001/jamapediatrics.2025.3459","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3459","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"4 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182686","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Error in Figure Title. 图标题错误。
IF 18 1区 医学
JAMA Pediatrics Pub Date : 2025-09-29 DOI: 10.1001/jamapediatrics.2025.4070
{"title":"Error in Figure Title.","authors":"","doi":"10.1001/jamapediatrics.2025.4070","DOIUrl":"10.1001/jamapediatrics.2025.4070","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":" ","pages":""},"PeriodicalIF":18.0,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481356/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reconsidering Off-Label Pediatric COVID-19 Vaccination. 重新考虑非适应症儿童COVID-19疫苗接种。
IF 18 1区 医学
JAMA Pediatrics Pub Date : 2025-09-29 DOI: 10.1001/jamapediatrics.2025.3462
Elizabeth Lanphier, Shannon Fyfe
{"title":"Reconsidering Off-Label Pediatric COVID-19 Vaccination.","authors":"Elizabeth Lanphier, Shannon Fyfe","doi":"10.1001/jamapediatrics.2025.3462","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3462","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":" ","pages":""},"PeriodicalIF":18.0,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145185840","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction. HPV疫苗引入17年后的人群水平有效性和群体保护。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-29 DOI: 10.1001/jamapediatrics.2025.3568
Aislinn DeSieghardt,Lili Ding,Aaron Ermel,Eduardo L Franco,Casey Dagnall,Darron R Brown,Sem Yao,Jessica A Kahn
{"title":"Population-Level Effectiveness and Herd Protection 17 Years After HPV Vaccine Introduction.","authors":"Aislinn DeSieghardt,Lili Ding,Aaron Ermel,Eduardo L Franco,Casey Dagnall,Darron R Brown,Sem Yao,Jessica A Kahn","doi":"10.1001/jamapediatrics.2025.3568","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3568","url":null,"abstract":"ImportanceHuman papillomavirus (HPV) vaccine clinical trials demonstrate high vaccine efficacy, but postlicensure population-level effectiveness data are needed to inform vaccination and cancer-prevention recommendations and policies. Little is known about effectiveness in adolescent girls and young adult women at high risk for HPV-related cancers or after 9-valent HPV vaccine (9vHPV) introduction.ObjectiveTo examine effectiveness and herd protection over the first 17 years after HPV vaccine introduction in adolescent girls and young women at increased risk for HPV infection and related cancers.Design, Setting, and ParticipantsThis cross-sectional study analyzed data from 6 surveillance studies from 2006 to 2023. A consecutive sample of sexually experienced adolescent girls and young women aged 13 to 26 years was recruited from clinical settings.ExposureParticipants were stratified by HPV vaccination status; those who received at least 1 vaccine dose were defined as vaccinated.Main Outcomes and MeasuresEffectiveness and herd protection were assessed by comparing proportions of vaccinated and unvaccinated participants positive for at least 1 type in the 2-valent vaccine (2vHPV), 4-valent vaccine (4vHPV), and 9vHPV in each of 6 studies. The prevalence of vaccine-type HPV was compared in vaccinated participants from surveillance studies 2 through 6 vs participants recruited in surveillance study 1, all of whom were unvaccinated. Inverse probability of treatment weighting with propensity score was used to balance between-wave differences in participant characteristics.ResultsOf 2335 participants (mean [SD] age, 18.9 [2.7] years; 1526 African American [65.4%], 13 Asian [0.6%], 6 Native American [0.3%], 582 White [24.9%], and 151 multiracial [6.5%]; 173 Hispanic [7.4%]), 1195 participants (51.2%) reported a sexually transmitted infection history and 1843 participants (78.9%) reported 2 or more male sex partners. Vaccination rates increased from 0 of 371 participants to 330 of 402 participants (82.1%) from 2006 to 2023. Among vaccinated participants, positivity decreased from 93 of 371 participants (27.7%) to 1 of 330 participants (0.4%) for 2vHPV (relative difference, 98.4%), 118 participants (35.4%) to 3 participants (2.1%) for 4vHPV (relative difference, 94.2%), and 163 participants (48.6%) to 21 participants (11.8%) for 9vHPV (relative difference, 75.7%). Among unvaccinated participants, positivity decreased from 93 of 371 participants (25.8%) to 3 of 72 participants (7.3%) for 2vHPV (relative difference, 71.6%), 118 participants (25.3%) to 4 participants (6.1%) for 4vHPV (relative difference, 75.8%), and 163 participants (42.7%) to 13 participants (31.1%) for 9vHPV (relative difference, 27.2%). For positivity rates, counts are raw numbers and percentages are propensity score adjusted. Adjusted logistic regression demonstrated significant reductions in the odds of at least 1 HPV type in the 2vHPV and 4vHPV among all (adjusted odds ratio [aOR], 0.03;","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"42 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145182685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery: A Randomized Clinical Trial. 有晚期早产风险的双胎孕妇产前使用皮质类固醇:一项随机临床试验。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-22 DOI: 10.1001/jamapediatrics.2025.3284
Seung Mi Lee,Hyun Soo Park,Soo Ran Choi,Jeesun Lee,Hyeon Ji Kim,Jee Yoon Park,Kyung Joon Oh,Geum Joon Cho,Min-Jeong Oh,Jin Hoon Chung,Sun Min Kim,Byoung Jae Kim,Suk Young Kim,Subeen Hong,Young Mi Jung,Se Jin Lee,Ji Su Seong,Haemin Kim,Sohee Oh,Joongyub Lee,Young Rang Jin,Ji Hoi Kim,Hee Young Cho,Chan-Wook Park,Joong Shin Park,Jong Kwan Jun
{"title":"Antenatal Corticosteroid in Twin-Pregnant Women at Risk of Late Preterm Delivery: A Randomized Clinical Trial.","authors":"Seung Mi Lee,Hyun Soo Park,Soo Ran Choi,Jeesun Lee,Hyeon Ji Kim,Jee Yoon Park,Kyung Joon Oh,Geum Joon Cho,Min-Jeong Oh,Jin Hoon Chung,Sun Min Kim,Byoung Jae Kim,Suk Young Kim,Subeen Hong,Young Mi Jung,Se Jin Lee,Ji Su Seong,Haemin Kim,Sohee Oh,Joongyub Lee,Young Rang Jin,Ji Hoi Kim,Hee Young Cho,Chan-Wook Park,Joong Shin Park,Jong Kwan Jun","doi":"10.1001/jamapediatrics.2025.3284","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3284","url":null,"abstract":"ImportanceRecent guidelines have recommended corticosteroid injection in women with singleton pregnancies at risk of late preterm delivery. However, the effectiveness of antenatal corticosteroid administration in women with twin pregnancies at risk of late preterm delivery has not been evaluated, and studies on this population are lacking.ObjectiveTo evaluate whether antenatal betamethasone administration reduces the risk of neonatal respiratory morbidity in late preterm twin neonates.Design, Setting, and ParticipantsIn this multicenter randomized trial, twin-pregnant women at 34 weeks 0 days to 36 weeks 5 days of gestation at risk of late preterm delivery were enrolled across 8 university-based clinical centers in Korea. Data were collected between May 2018 and July 2024. Intention-to-treat analysis was performed.InterventionThe participants received 2 injections of betamethasone or placebo after randomization (1:1).Main Outcomes and MeasuresThe primary outcome was perinatal death within 72 hours after birth or severe neonatal respiratory morbidity. The exploratory outcomes were mild neonatal respiratory morbidities, other neonatal respiratory morbidities, other neonatal complications, or maternal complications.ResultsA total of 812 participants were randomized and analyzed, with 410 in the intervention group (median [IQR] age, 35 [33-37] years) and 402 in the placebo group (median [IQR] age, 35 [32-38] years). Among 1620 neonates (818 in the intervention group and 802 in the placebo group), there were no perinatal deaths in either group, and severe neonatal respiratory morbidity occurred in 99 neonates (6.1%), with lower risk in the betamethasone group than in the placebo group (39 [4.8%] vs 60 [7.5%]; relative risk [RR], 0.64 [95% CI, 0.42-0.98]). For the exploratory outcomes, continuous positive airway pressure use for 2 hours or more (RR, 0.58 [95% CI, 0.35-0.95]) and transient tachypnea of the newborn (RR, 0.47 [95% CI, 0.25-0.89]) were lower in the betamethasone group. The risk of primary outcome and mild respiratory morbidities was reduced only in neonates delivered between 12 hours or more and less than 7 days after the first betamethasone administration. The risk of neonatal hypoglycemia was increased in the betamethasone group (128 [15.6%] vs 94 [11.7%]; RR, 1.33 [95% CI, 1.01-1.75]), but the risk of neonatal sepsis or maternal chorioamnionitis did not differ between the 2 groups.Conclusions and RelevanceIn this randomized clinical trial, antenatal betamethasone administration in women with twin pregnancies at risk of late preterm delivery significantly reduced the risk of neonatal respiratory morbidity. The outcomes from this study could serve as a valuable reference in clinical management of twin pregnancies at risk of late preterm delivery.Trial RegistrationClinicalTrials.gov Identifier: NCT03547791.","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"16 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103487","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considerations for Studying Parental Technology Use in a Child's Presence. 在孩子面前研究父母使用技术的考虑。
IF 18 1区 医学
JAMA Pediatrics Pub Date : 2025-09-22 DOI: 10.1001/jamapediatrics.2025.3267
Jianing Miao, Jun Li, Yaling Li
{"title":"Considerations for Studying Parental Technology Use in a Child's Presence.","authors":"Jianing Miao, Jun Li, Yaling Li","doi":"10.1001/jamapediatrics.2025.3267","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3267","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":" ","pages":""},"PeriodicalIF":18.0,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145113126","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Long-Read Sequencing Test for Genetic Disease Diagnosis. 基因疾病诊断的临床长读测序试验。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-22 DOI: 10.1001/jamapediatrics.2025.3320
Isabelle Thiffault,Emily Farrow,Cassandra Barrett,Meadow Scott,Amy Ross,John C Means,Warren A Cheung,Adam F Johnson,Boryana Koseva,Rebecca McLennan,Elin Grundberg,Chengpeng Bi,Carl Schwendinger-Schreck,Byunggil Yoo,Jeffrey J Johnston,Florencia Del Viso,Vitoria Paolillo,John Herriges,Lei Zhang,Margaret Gibson,Ana S A Cohen,Joe Alaimo,Carol J Saunders,Tomi Pastinen
{"title":"Clinical Long-Read Sequencing Test for Genetic Disease Diagnosis.","authors":"Isabelle Thiffault,Emily Farrow,Cassandra Barrett,Meadow Scott,Amy Ross,John C Means,Warren A Cheung,Adam F Johnson,Boryana Koseva,Rebecca McLennan,Elin Grundberg,Chengpeng Bi,Carl Schwendinger-Schreck,Byunggil Yoo,Jeffrey J Johnston,Florencia Del Viso,Vitoria Paolillo,John Herriges,Lei Zhang,Margaret Gibson,Ana S A Cohen,Joe Alaimo,Carol J Saunders,Tomi Pastinen","doi":"10.1001/jamapediatrics.2025.3320","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3320","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"162 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103491","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Considerations for Studying Parental Technology Use in a Child's Presence-Reply. 研究父母在孩子在场时使用技术的考虑-回复。
IF 26.1 1区 医学
JAMA Pediatrics Pub Date : 2025-09-22 DOI: 10.1001/jamapediatrics.2025.3270
Marcelo Toledo-Vargas,Kar Hau Chong,Anthony D Okely
{"title":"Considerations for Studying Parental Technology Use in a Child's Presence-Reply.","authors":"Marcelo Toledo-Vargas,Kar Hau Chong,Anthony D Okely","doi":"10.1001/jamapediatrics.2025.3270","DOIUrl":"https://doi.org/10.1001/jamapediatrics.2025.3270","url":null,"abstract":"","PeriodicalId":14683,"journal":{"name":"JAMA Pediatrics","volume":"22 1","pages":""},"PeriodicalIF":26.1,"publicationDate":"2025-09-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103489","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信